EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial

Xunuo Chen iD, Mengyun Lei, Jun Tang, Huawei Wang, Jiawei Chen, Yanxin Liu iD, Shuting Li, Fang Liu, Yonge Wang, Zhiqiang Li, Zhe Dai iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0343078 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2026. Verfasst von Xunuo Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Fecal Microbiota Transplantation. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Dysbiosis of gut microbiota plays a key role in type 1 diabetes mellitus (T1DM). Fecal microbiota transplantation represents a novel therapeutic avenue. We hypothesize that youth-derived fecal microbiota transplantation (yFMT) can remodel the gut microecosystem and improve clinical outcomes. This pilot trial aims to assess the feasibility, safety, and preliminary efficacy of yFMT in adults with T1DM. Methods and analysis This single-center, randomized, double-blind, placebo-controlled pilot study will enroll adults with T1DM who have suboptimal glycemic outcomes (glycated hemoglobin [HbA1c] of 7.0–14.0% or time in range [TIR] 70% and time below range

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Fecal Microbiota TransplantationHumansPilot ProjectsAdultDouble-Blind MethodFemaleGlycated HemoglobinMaleFeasibility StudiesYoung AdultRandomized Controlled Trials as TopicTreatment OutcomeBlood GlucoseAdolescentContinuous Glucose MonitoringGastrointestinal MicrobiomeInsulin

Substanzen

Glycated HemoglobinBlood GlucoseInsulin

Autor:innen und Institutionen

  • Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Department of Clinical Nutrition, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • State Key Laboratory of Metabolism and Regulation in Complex Organisms, College of Life Sciences, Wuhan University, Wuhan, China.

ORCID-Profile: Xunuo Chen, Yanxin Liu, Zhe Dai

Förderung

  • the National Key Research and Development Program of China

Zitieren

APA

Chen, X., Lei, M., Tang, J., Wang, H., Chen, J., Liu, Y., Li, S., Liu, F., Wang, Y., Li, Z., & Dai, Z. (2026). Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial. PLOS One. https://doi.org/10.1371/journal.pone.0343078

Vancouver

Chen X, Lei M, Tang J, Wang H, Chen J, Liu Y, et al. Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial. PLOS One. 2026. doi:10.1371/journal.pone.0343078

BibTeX
@article{Chen2026,
  author = {Chen, Xunuo and Lei, Mengyun and Tang, Jun and Wang, Huawei and Chen, Jiawei and Liu, Yanxin and Li, Shuting and Liu, Fang and Wang, Yonge and Li, Zhiqiang and Dai, Zhe},
  title = {Efficacy, safety, and feasibility of youth-derived fecal microbiota transplantation among adults with type 1 diabetes mellitus: A protocol of Pilot Randomized Controlled Trial},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0343078}
}
Kostenlos starten →